𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term remission of lymphocytic hypereosinophilic syndrome with imatinib mesylate

✍ Scribed by Anna Christoforidou; Ioannis Kotsianidis; Dimitrios Margaritis; Athanasios Anastasiadis; Eudoxia Douvali; Costas Tsatalas

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
186 KB
Volume
87
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Imatinib mesylate for lymphocytic varian
Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome
✍ Grzegorz Helbig πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 427 KB πŸ‘ 2 views

## Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome To the editor: With a great interest I read a paper by Christoforidou et al. showing the high efficacy of imatinib mesylate (IM) in a patient with L-HES and undetectable FIP1L1-PDGFRA (F/P) fusion transcript. However, afte

Imatinib mesylate for lymphocytic varian
Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome: A response
✍ Anna Christoforidou πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 604 KB

## Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome To the editor: With a great interest I read a paper by Christoforidou et al. [1] showing the high efficacy of imatinib mesylate (IM) in a patient with L-HES and undetectable FIP1L1-PDGFRA (F/P) fusion transcript. However, a